Christopher J. Coughlin
Independent DirectorMr. Christopher J. Coughlin, also known as Chris, served as Chairman at Karuna Therapeutics, Inc. since January 03, 2023 until March 18, 2024. He serves as Director at Centene Corporation since January 05, 2022. He serves as Lead Independent Director at Karuna Therapeutics, Inc. since March 2022 and serves as its Member of Scientific Advisory Board and served as its Independent Director since April 24, 2020 until March 2022. He served as a Director at Prestige Consumer Healthcare Inc since July 30, 2019 until August 1, 2023. He had been an Independent Director at Allergan plc since July 2014 until May 8, 2020 and served as its Lead Independent Director since October 26, 2016 until May 8, 2020. He served as a Senior Advisor to the CEO and Board of Directors at Tyco International Ltd. from 2010 to September 2012. Mr. Coughlin served as the Chief Financial Officer and Executive Vice President of Tyco International plc from March 7, 2005 to December 1, 2010. He served as the Chief Operating Officer of Interpublic Group of Companies, Inc. from June 16, 2003 to December 2004 and served as its Chief Financial Officer from August 2003 to June 2004 and Executive Vice President from August 2003 to December 2004. Mr. Coughlin served as the Chief Financial Officer and Executive Vice President of Pharmacia Corporation from 1998 to 2003. He joined Pharmacia Corporation in 1998. He served as an Executive Vice President and Chief Financial Officer of Pharmacia & Upjohn LLC (P&U), a subsidiary of Pharmacia from March 1998 to March 2000; President of Nabisco International from 1997 to March 1998 and Executive Vice President and Chief Financial Officer of Nabisco Holdings Corp. from 1996 to 1997. From 1997 to 1998, he was President of International at Nabisco Group Holdings. Mr. Coughlin entered the pharmaceutical industry in 1981 when he joined STWB Inc. where, he held a number of management positions, including Vice President of Finance International, Vice President of Worldwide Consumer Healthcare and Chief Financial Officer until 1996. He began his career with Arthur Young & Company. Mr. Coughlin served as Director at Prestige Brands Inc since July 2019 until 2023. He served as the Chairman of Dun & Bradstreet Corp. from October 7, 2013 to December 7, 2016. Mr. Coughlin had been a Director of Alexion Pharmaceuticals, Inc. since July 2014 until July 21, 2021. Mr. Coughlin serves as a Director of Mallinckrodt LLC. He served as a Director of Dun & Bradstreet Corp. since December 6, 2004 until May 31, 2017. He served as a Director of Hologic, Inc. from March 2, 2016 to March 27, 2017. He served as an Independent Director of Forest Laboratories, LLC since August 2011. He served as a Director at Perrigo Company. He served as a Director at Dipexium Pharmaceuticals, LLC from November 2012 to July 3, 2014. He served as a Director of Covidien PLC (Covidien, Ltd) since June 29, 2007 until January 26, 2015. He served as a Lead Independent Director at Dun & Bradstreet from August 2010 to October 7, 2013. He served as a Director of Monsanto Company since March 2000. He served as a Director of Amersham Biosciences Corporation since July 2000. He served as a Corporate Audit Director of STWB Inc. He served as a Director of Interpublic Group of Companies Inc. from July 2003 to December 31, 2004. From 1981 to 1996, he held various positions, including Chief Financial Officer, at STWB Inc. (Sterling Winthrop). Mr. Coughlin was named a 2022 Director of the Year by the New Jersey Chapter of the NACD for his leadership in public corporate governance. In 2015, Mr. Coughlin was also named the NACD Corporate Director of the Year. Mr. Coughlin holds a B. S. Degree in Accounting from Boston College in 1974.
Positions
- Company NameCentene CorporationStock CodeCNCPositionIndependent DirectorColleagues
- SMSarah M. LondonCEO & Director
- FHFrederick Henry EppingerIndependent Chairman
- ALAndrew Lynn AsherExecutive VP & CFO
- SRSusan R. SmithChief Operating Officer
- CAChristopher Andrew KosterExecutive VP, General Counsel & Secretary
- TMTanya M. McNallySenior VP & Chief People Officer
- JLJessica L. BlumeIndependent Director
- TRTheodore Rapp SamuelsIndependent Director
